CVE-2026-24217NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file.
Updated under an hour ago ()
Does this affect you?
It affects nvidia bionemo_framework. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
- CVSS
- 8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-29
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jul 23, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
nvidia bionemo_framework nvidia:bionemo_framework | before 2026-04-03 | NVD |
References
- https://nvd.nist.gov/vuln/detail/CVE-2026-24217us-government-resource
- https://nvidia.custhelp.com/app/answers/detail/a_id/5831vendor-advisory
- https://www.cve.org/CVERecord?id=CVE-2026-24217third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.